The
blood-brain barrier blocks the development of biologic pharmaceuticals
for brain
ArmaGen® provides
platform technology solutions to the 'blood-brain barrier' problem,
and can non-invasively target recombinant proteins, therapeutic
monoclonal antibodies, and siRNA to the brain
|
Brain
blood vessels form the blood-brain barrier and block drug access
to the brain
|
| News
Feb. 1, 2010 |
ArmaGen® receives
Notice of Allowance from USPTO on broad therapeutic
antibody delivery patent
Therapeutic
antibodies for the human brain. The
U.S. Patent and Trademark Office has issued
a formal Notice of Allowance for the lead patent
in ArmaGen’s platform technology on the
delivery across the human blood-brain barrier
(BBB) of therapeutic....
|
|
|
